Jana Bergholtz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jana Bergholtz has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Axel Wolf
Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden
2 shared publications - Ida Björkman
Centre for Person-Centred Care (GPCC), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2 shared publications Axel Wolf
Centre for person-centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden/OsloMet University, Oslo, Norway
1 shared publication- Carlos Casaus
Alliance to Cure Cavernous Malformation, Charlottesville, VA, USA
1 shared publication - Christopher J. Weir
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK
1 shared publication - Cornelia Lee
Alliance to Cure Cavernous Malformation Charlottesville VA USA
1 shared publication
Latest Publications
- Open Access
- 11 June 2026
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 12 (1)
Reducing tokenism in patient and public involvement by integrating the Gothenburg person-centred care framework, relational bridges and impact log – a co-produced position paper
Patient and public involvement (PPI) is widely promoted in health research, care services and governance. It is increasingly framed as a matter of rights, dignity and accountability. Despite strong policy support, PPI remains conceptually diverse, unevenly implemented and persistently vulnerable to tokenism, with PPI contributors often reporting unclear influence and weak feedback. Recent literature has highlighted the need for stronger ethical anchoring of PPI beyond standards, frameworks and reporting requirements. This position paper explores how tokenism in PPI can be reduced by adapting established steps from the Gothenburg person-centred care (PCC) framework, grounded in Paul Ricœur’s “little ethics”, to involvement practices beyond the clinical encounter. We propose person-centred PPI (PC-PPI) as a practice-oriented approach comprising three core collaborative steps: (1) Initiating the partnership through shared narrative, (2) Working the partnership through explicit negotiation of decision rights, and (3) Safeguarding the partnership through documentation and follow-up, as well as three organisational readiness domains that function as ethical minimum requirements for reflective self-assessment for all involved. PC-PPI shifts the focus from general levels of influence to specifying and documenting meaningful decision rights for concrete activities, supported by practical tools such as a relational bridge framework and an impact log. The feedback loop supports contributor empowerment during the involvement process by making influence visible, explainable and contestable over time. Organisational readiness domains further clarify that PC-PPI cannot rely on willingness alone, but requires sustained ethical, structural and accountability support. By translating person-centred ethics into concrete steps and organisational practices, PC-PPI offers a pragmatic way to reduce tokenism while remaining adaptable to context, resources and ongoing learning. The approach has implications for professionals, organisations, and policymakers seeking to move from formal PPI requirements towards auditable, ethically grounded partnership practices. The online version contains supplementary material available at 10.1186/s40900-026-00920-6. Service users, patients, carers, and community representatives can actively contribute to healthcare improvement and research. This is also called patient and public involvement (PPI). However, PPI is not always experienced as meaningful. People may be invited too late. They may have little influence. They may also receive little or no feedback about how their input was used. This can be discouraging. We explored how PPI could be done in a more transparent way. We drew on ideas from person-centred care (PCC), where similar ethical challenges have been addressed. We adapted these ideas to PPI and call this approach person-centred PPI (PC-PPI). PC-PPI has three practical steps: 1. Listening carefully to develop a shared understanding of what is most important, 2. Negotiating decision rights for each activity, 3. Documenting how input is used and feeding this back over time. We also describe three areas where organisations need to be ready. This includes support for both PPI contributors and professionals, e.g. through preparation or skills training. Organisations need routines for fair and accessible participation. They also need clear systems for accountability. PC-PPI aims for partnership. It does not promise that every suggestion will be adopted. Instead, it commits to transparent processes that make involvement clear, fair and visible. PPI contributors can see how they made a difference. Organisations can demonstrate transparent decision-making through documentation and follow-up. We hope this approach helps reduce tokenism, strengthens trust and supports more meaningful partnerships. The online version contains supplementary material available at 10.1186/s40900-026-00920-6.
- 11 June 2026
- Published by Springer Nature in Research Involvement and Engagement
- Vol. 12 (1)
Open AccessReducing tokenism in patient and public involvement by integrating the Gothenburg person-centred care framework, relational bridges and impact log – a co-produced position paper
Patient and public involvement (PPI) is widely promoted in health research, care services and governance. It is increasingly framed as a matter of rights, dignity and accountability. Despite strong policy support, PPI remains conceptually diverse, unevenly implemented and persistently vulnerable to tokenism, with PPI contributors often reporting unclear influence and weak feedback. Recent literature has highlighted the need for stronger ethical anchoring of PPI beyond standards, frameworks and reporting requirements. This position paper explores how tokenism in PPI can be reduced by adapting established steps from the Gothenburg person-centred care (PCC) framework, grounded in Paul Ricœur’s “little ethics”, to involvement practices beyond the clinical encounter. We propose person-centred PPI (PC-PPI) as a practice-oriented approach comprising three core collaborative steps: (1) Initiating the partnership through shared narrative, (2) Working the partnership through explicit negotiation of decision rights, and (3) Safeguarding the partnership through documentation and follow-up, as well as three organisational readiness domains that function as ethical minimum requirements for reflective self-assessment for all involved. PC-PPI shifts the focus from general levels of influence to specifying and documenting meaningful decision rights for concrete activities, supported by practical tools such as a relational bridge framework and an impact log. The feedback loop supports contributor empowerment during the involvement process by making influence visible, explainable and contestable over time. Organisational readiness domains further clarify that PC-PPI cannot rely on willingness alone, but requires sustained ethical, structural and accountability support. By translating person-centred ethics into concrete steps and organisational practices, PC-PPI offers a pragmatic way to reduce tokenism while remaining adaptable to context, resources and ongoing learning. The approach has implications for professionals, organisations, and policymakers seeking to move from formal PPI requirements towards auditable, ethically grounded partnership practices. The online version contains supplementary material available at 10.1186/s40900-026-00920-6. Service users, patients, carers, and community representatives can actively contribute to healthcare improvement and research. This is also called patient and public involvement (PPI). However, PPI is not always experienced as meaningful. People may be invited too late. They may have little influence. They may also receive little or no feedback about how their input was used. This can be discouraging. We explored how PPI could be done in a more transparent way. We drew on ideas from person-centred care (PCC), where similar ethical challenges have been addressed. We adapted these ideas to PPI and call this approach person-centred PPI (PC-PPI). PC-PPI has three practical steps: 1. Listening carefully to develop a shared understanding of what is most important, 2. Negotiating decision rights for each activity, 3. Documenting how input is used and feeding this back over time. We also describe three areas where organisations need to be ready. This includes support for both PPI contributors and professionals, e.g. through preparation or skills training. Organisations need routines for fair and accessible participation. They also need clear systems for accountability. PC-PPI aims for partnership. It does not promise that every suggestion will be adopted. Instead, it commits to transparent processes that make involvement clear, fair and visible. PPI contributors can see how they made a difference. Organisations can demonstrate transparent decision-making through documentation and follow-up. We hope this approach helps reduce tokenism, strengthens trust and supports more meaningful partnerships. The online version contains supplementary material available at 10.1186/s40900-026-00920-6.
- Open Access
- 8 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0350991
Leadership education to support person-centred health and social care: A scoping review of empirical literature
The purpose of this scoping review was to map evidence on leadership education to support person-centred care. Specifically, the review aimed to identify the key content of such education, the educational methods used, the reported results, and gaps in the existing literature. The review was conducted using the Joanna Briggs Institute methodology for scoping reviews and reported in accordance with PRISMA-ScR guidelines. Peer-reviewed empirical literature on leadership education for people with leadership roles in health and social were included, without restrictions on publication year or study design. Qualitative, quantitative, and mixed-methods designs were eligible. Educational methods were summarised descriptively, and education content and results were iteratively synthesised and categorised. Methodological quality was not formally assessed, consistent with scoping review methodology. Of 2548 identified records, 22 publications met the eligibility criteria. Leadership education interventions were predominantly conducted in Northern Europe and mainly targeted registered nurses in leadership roles. Educational content commonly addressed leadership theories and styles, person-centredness, and facilitation skills. Educational methods were largely based on longitudinal, work-based learning approaches, and reported results primarily reflected perceived improvements in leadership practices, workplace culture, and care practice outcomes. However, outcomes were largely self-reported, context-specific, and seldom assessed using standardised or comparative measures. Interpretation of the findings is limited by the small number of publications, the predominance of qualitative and non-comparative designs, and the narrow geographical and professional focus of the evidence. These limitations restrict conclusions regarding effectiveness, generalisability, scalability, and sustained system-level impact. Despite these limitations, the findings suggest that leadership education may support leadership practices and care improvement. The review identifies substantial gaps in the global evidence base, highlighting the need for more diverse, theory-informed, and rigorously evaluated leadership education that engages multiple professional groups, incorporates patient and relative perspectives, and examines implementation and transferability across varied health and social care contexts.
- 8 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0350991
Open AccessLeadership education to support person-centred health and social care: A scoping review of empirical literature
The purpose of this scoping review was to map evidence on leadership education to support person-centred care. Specifically, the review aimed to identify the key content of such education, the educational methods used, the reported results, and gaps in the existing literature. The review was conducted using the Joanna Briggs Institute methodology for scoping reviews and reported in accordance with PRISMA-ScR guidelines. Peer-reviewed empirical literature on leadership education for people with leadership roles in health and social were included, without restrictions on publication year or study design. Qualitative, quantitative, and mixed-methods designs were eligible. Educational methods were summarised descriptively, and education content and results were iteratively synthesised and categorised. Methodological quality was not formally assessed, consistent with scoping review methodology. Of 2548 identified records, 22 publications met the eligibility criteria. Leadership education interventions were predominantly conducted in Northern Europe and mainly targeted registered nurses in leadership roles. Educational content commonly addressed leadership theories and styles, person-centredness, and facilitation skills. Educational methods were largely based on longitudinal, work-based learning approaches, and reported results primarily reflected perceived improvements in leadership practices, workplace culture, and care practice outcomes. However, outcomes were largely self-reported, context-specific, and seldom assessed using standardised or comparative measures. Interpretation of the findings is limited by the small number of publications, the predominance of qualitative and non-comparative designs, and the narrow geographical and professional focus of the evidence. These limitations restrict conclusions regarding effectiveness, generalisability, scalability, and sustained system-level impact. Despite these limitations, the findings suggest that leadership education may support leadership practices and care improvement. The review identifies substantial gaps in the global evidence base, highlighting the need for more diverse, theory-informed, and rigorously evaluated leadership education that engages multiple professional groups, incorporates patient and relative perspectives, and examines implementation and transferability across varied health and social care contexts.
- Open Access
- 1 March 2025
- Published by National Institute for Health and Care Research in Efficacy and Mechanism Evaluation
- p. 1-21
Developing a Randomised Efficacy PREcision medicine Platform trial design for Cavernomas: the CARE PREP study
Background: Symptomatic cerebral cavernous malformations are a rare sporadic or familial disease, which may cause haemorrhagic strokes or epileptic seizures. In 2015, a James Lind Alliance Priority Setting Partnership ranked targeted drug therapies as fourth of the top 10 research priorities for cerebral cavernous malformations. There are no disease-modifying drugs for cerebral cavernous malformations, but there are several promising candidates with proof of concept in human and animal studies. There are no platform trials for cerebral cavernous malformations. Objectives: (1) Consolidate and initiate international collaborations between cerebral cavernous malformations researchers, cerebral cavernous malformations patient and public involvement groups, cerebral cavernous malformations research networks, and commercial partners; (2) Finalise a protocol for an efficient, international platform trial of multiple drugs using precision medicine (sporadic vs. familial cerebral cavernous malformations) that is both feasible and acceptable to patients and regulators; (3) Estimate the research, support and treatment costs of the platform trial and apply to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation Programme. Methods: A National Institute for Health and Care Research Efficacy and Mechanism Evaluation Application Acceleration Award funded this project from September 2022 to August 2023. A trial manager supported the Chief Investigator in growing and leading a multidisciplinary international collaboration, including a patient and public involvement advisory group, in a series of meetings to optimise study design, equality, diversity and inclusion. Edinburgh Innovations established connections with commercial partners with candidate drugs. We assessed feasibility by scoping potential funding agencies, and clinical networks that might support recruitment internationally. We agreed upon a final design and sample size through a process of consensus, enlightened by scenarios simulated by statisticians varying key parameters, which informed a comprehensive estimate of the budget for a stage 1 submission to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation programme. Setting: International collaboration. Participants: Clinicians, researchers, patient and public involvement groups, cerebral cavernous malformations research networks, and commercial partners. Results: There was one face-to-face meeting, nine virtual meetings of the co-applicants, and five meetings of the patient and public involvement advisory group. We identified 14 countries with clinical leadership, a cerebral cavernous malformation research network, and a funding agency that could support an international trial. We contacted three potential commercial partners and obtained one letter of collaboration. We sent monthly newsletters to collaborators. Our meetings and simulations concluded that a three-arm, two-stage multiarm multistage adaptive treatment selection randomised trial design was suitable for evaluating aspirin and propranolol as the first two interventions compared with standard care in a platform trial. We submitted a stage 1 proposal for this Cavernous malformations A Randomised Efficacy MAster Protocol study to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation call 23/15 in May 2023, and a resubmission was encouraged. Limitations: The National Institute for Health and Care Research Efficacy and Mechanism Evaluation funding committee would have required further justification for the choice of the intermediate phenotype used for treatment selection, biomarker validation work, and details about the pipeline of interventions. Future work: We have addressed these limitations and re-applied to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation programme. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation (EME) programme as award number NIHR153811.
- 1 March 2025
- Published by National Institute for Health and Care Research in Efficacy and Mechanism Evaluation
- p. 1-21
Open AccessDeveloping a Randomised Efficacy PREcision medicine Platform trial design for Cavernomas: the CARE PREP study
Background: Symptomatic cerebral cavernous malformations are a rare sporadic or familial disease, which may cause haemorrhagic strokes or epileptic seizures. In 2015, a James Lind Alliance Priority Setting Partnership ranked targeted drug therapies as fourth of the top 10 research priorities for cerebral cavernous malformations. There are no disease-modifying drugs for cerebral cavernous malformations, but there are several promising candidates with proof of concept in human and animal studies. There are no platform trials for cerebral cavernous malformations. Objectives: (1) Consolidate and initiate international collaborations between cerebral cavernous malformations researchers, cerebral cavernous malformations patient and public involvement groups, cerebral cavernous malformations research networks, and commercial partners; (2) Finalise a protocol for an efficient, international platform trial of multiple drugs using precision medicine (sporadic vs. familial cerebral cavernous malformations) that is both feasible and acceptable to patients and regulators; (3) Estimate the research, support and treatment costs of the platform trial and apply to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation Programme. Methods: A National Institute for Health and Care Research Efficacy and Mechanism Evaluation Application Acceleration Award funded this project from September 2022 to August 2023. A trial manager supported the Chief Investigator in growing and leading a multidisciplinary international collaboration, including a patient and public involvement advisory group, in a series of meetings to optimise study design, equality, diversity and inclusion. Edinburgh Innovations established connections with commercial partners with candidate drugs. We assessed feasibility by scoping potential funding agencies, and clinical networks that might support recruitment internationally. We agreed upon a final design and sample size through a process of consensus, enlightened by scenarios simulated by statisticians varying key parameters, which informed a comprehensive estimate of the budget for a stage 1 submission to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation programme. Setting: International collaboration. Participants: Clinicians, researchers, patient and public involvement groups, cerebral cavernous malformations research networks, and commercial partners. Results: There was one face-to-face meeting, nine virtual meetings of the co-applicants, and five meetings of the patient and public involvement advisory group. We identified 14 countries with clinical leadership, a cerebral cavernous malformation research network, and a funding agency that could support an international trial. We contacted three potential commercial partners and obtained one letter of collaboration. We sent monthly newsletters to collaborators. Our meetings and simulations concluded that a three-arm, two-stage multiarm multistage adaptive treatment selection randomised trial design was suitable for evaluating aspirin and propranolol as the first two interventions compared with standard care in a platform trial. We submitted a stage 1 proposal for this Cavernous malformations A Randomised Efficacy MAster Protocol study to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation call 23/15 in May 2023, and a resubmission was encouraged. Limitations: The National Institute for Health and Care Research Efficacy and Mechanism Evaluation funding committee would have required further justification for the choice of the intermediate phenotype used for treatment selection, biomarker validation work, and details about the pipeline of interventions. Future work: We have addressed these limitations and re-applied to the National Institute for Health and Care Research Efficacy and Mechanism Evaluation programme. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Efficacy and Mechanism Evaluation (EME) programme as award number NIHR153811.
- Open Access
Patient and public involvement in healthcare: a systematic mapping review of systematic reviews – identification of current research and possible directions for future research
Objectives To provide an overview of patient and public involvement (PPI) in the mesolevel and macrolevel of healthcare (different from PPI in research) and identify directions for future research by mapping contexts, terminology, conceptual frameworks, measured outcomes and research gaps. Design Mapping review of systematic reviews. A patient coresearcher (JB) was involved in all stages. A broad search strategy was applied to capture the variation in terminology. Data sources MEDLINE, CINAHL and PsycINFO were searched from 1 January 2001 to 5 December 2022. Eligibility criteria We included systematic reviews of empirical studies focusing on PPI in the mesolevel and macrolevel of healthcare. Data extraction and synthesis Three independent reviewers used standardised methods to screen studies and extract data. Thematic categories were created inductively through iteration. The results were organised in narrative, visual or tabular formats. Results 4419 identified records were screened. 37 systematic reviews were eligible for inclusion. Most studies were narrative syntheses (N=26). Identified context categories were PPI for healthcare quality improvement (22%), patient safety (8%), community-based initiatives (27%), peer support (16 %) and education of healthcare professionals (27%). A wide range of terms was used to discuss PPI, with community participation being the most common. 28 reviews reported on frameworks, conceptual guidance and/or policy documents. Nine different types of outcomes were identified. The research gap pointed out most frequently is the lack of studies of robust designs that allow for replication and long-term follow-up, followed by studies on cost-effectiveness and resources needed. There is a need for consensus on the use of terminology. Conclusions This mapping review sheds light on the evolving landscape of PPI in healthcare. To advance the field, future research should prioritise rigorous study designs, cost-effectiveness assessments and consensus-building efforts to create a more unified and impactful approach for PPI in healthcare.
Open AccessPatient and public involvement in healthcare: a systematic mapping review of systematic reviews – identification of current research and possible directions for future research
Objectives To provide an overview of patient and public involvement (PPI) in the mesolevel and macrolevel of healthcare (different from PPI in research) and identify directions for future research by mapping contexts, terminology, conceptual frameworks, measured outcomes and research gaps. Design Mapping review of systematic reviews. A patient coresearcher (JB) was involved in all stages. A broad search strategy was applied to capture the variation in terminology. Data sources MEDLINE, CINAHL and PsycINFO were searched from 1 January 2001 to 5 December 2022. Eligibility criteria We included systematic reviews of empirical studies focusing on PPI in the mesolevel and macrolevel of healthcare. Data extraction and synthesis Three independent reviewers used standardised methods to screen studies and extract data. Thematic categories were created inductively through iteration. The results were organised in narrative, visual or tabular formats. Results 4419 identified records were screened. 37 systematic reviews were eligible for inclusion. Most studies were narrative syntheses (N=26). Identified context categories were PPI for healthcare quality improvement (22%), patient safety (8%), community-based initiatives (27%), peer support (16 %) and education of healthcare professionals (27%). A wide range of terms was used to discuss PPI, with community participation being the most common. 28 reviews reported on frameworks, conceptual guidance and/or policy documents. Nine different types of outcomes were identified. The research gap pointed out most frequently is the lack of studies of robust designs that allow for replication and long-term follow-up, followed by studies on cost-effectiveness and resources needed. There is a need for consensus on the use of terminology. Conclusions This mapping review sheds light on the evolving landscape of PPI in healthcare. To advance the field, future research should prioritise rigorous study designs, cost-effectiveness assessments and consensus-building efforts to create a more unified and impactful approach for PPI in healthcare.
- Open Access
- 28 December 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (S1) , 648
Patient and public involvement (PPI) in health care: A systematic mapping review of systematic reviews
Introduction: While patient and public involvement (PPI) is increasingly required by policymakers and funding agencies, the vast amount of literature on this topic makes it difficult for stakeholders who are at the beginning of their journey to find guidance on conceptual frameworks, successful methods, and good examples for PPI in contexts/settings similar to their own. Although there are various conceptual frameworks available, especially for PPI in research [1], little is known about which conceptual frameworks are successfully being implemented in health care practice. Recently, [2] highlighted different theoretical traditions and the need to further develop theory-driven approaches to guide the process of involvement in more strategic ways. Objectives: The overarching goal of this mapping review is to identify systematic reviews on PPI in health care practice worldwide to: further examine the different conceptualizations of PPI in health care used in the literature (i.e., definitions, models, frameworks); provide an overview of the methods used to promote and implement PPI in health care; provide an overview of contextual factors such as: - the settings in which PPI is implemented in health care; - the demographic characteristics of the patients and the publics involved; - the desired, achieved and reported outcomes of PPI; and - the outcomes used to measure the effectiveness of PPI. Method and preliminary results: Methodologically, a mapping review design was chosen to give an overview of findings, identify research gaps in the field and to provide the audience with intuitive and accessible visualisations. This review is co-designed and carried out in partnership with a patient (JB), who is also an active volunteer, representative and chair of a patient organization. In December 2021, the study was registered on the Open Science Forum (https://osf.io/9b5j3) and an initial search on PubMed, Cinahl and PsycInfo resulted in 3763 articles after deduplication. Titles and abstracts were screened independently by 2 reviewers (VC, JB) and 95 articles were selected for full-text review. 35 articles were included in the study for detailed data extraction (VC, IB, JB). The themes covered in the articles range from PPI in the education and skills training of health care staff, PPI in design, development and evaluation of health care services and products, quality improvement, patient safety, infectious disease control, crisis management, mental health and health promotion. While data extraction has been completed, data synthesis is still ongoing at the time of abstract submission. An updated search is planned for December 2022. With this mapping review of systematic reviews, we hope to provide an overview of the field and some guidance to those wanting to involve patients, caregivers and the public in their upcoming projects. References [1] Greenhalgh T, et al. Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot. Health Expectations 2019;22(4):785-801. DOI: 10.1111/hex.12888. [2] Ocloo J, et al. Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews. Health Research Policy and Systems 2021;19(1):8. DOI: 10.1186/s12961-020-00644-3.
- 28 December 2023
- Published by Ubiquity Press, Ltd. in International Journal of Integrated Care
- Vol. 23 (S1) , 648
Open AccessPatient and public involvement (PPI) in health care: A systematic mapping review of systematic reviews
Introduction: While patient and public involvement (PPI) is increasingly required by policymakers and funding agencies, the vast amount of literature on this topic makes it difficult for stakeholders who are at the beginning of their journey to find guidance on conceptual frameworks, successful methods, and good examples for PPI in contexts/settings similar to their own. Although there are various conceptual frameworks available, especially for PPI in research [1], little is known about which conceptual frameworks are successfully being implemented in health care practice. Recently, [2] highlighted different theoretical traditions and the need to further develop theory-driven approaches to guide the process of involvement in more strategic ways. Objectives: The overarching goal of this mapping review is to identify systematic reviews on PPI in health care practice worldwide to: further examine the different conceptualizations of PPI in health care used in the literature (i.e., definitions, models, frameworks); provide an overview of the methods used to promote and implement PPI in health care; provide an overview of contextual factors such as: - the settings in which PPI is implemented in health care; - the demographic characteristics of the patients and the publics involved; - the desired, achieved and reported outcomes of PPI; and - the outcomes used to measure the effectiveness of PPI. Method and preliminary results: Methodologically, a mapping review design was chosen to give an overview of findings, identify research gaps in the field and to provide the audience with intuitive and accessible visualisations. This review is co-designed and carried out in partnership with a patient (JB), who is also an active volunteer, representative and chair of a patient organization. In December 2021, the study was registered on the Open Science Forum (https://osf.io/9b5j3) and an initial search on PubMed, Cinahl and PsycInfo resulted in 3763 articles after deduplication. Titles and abstracts were screened independently by 2 reviewers (VC, JB) and 95 articles were selected for full-text review. 35 articles were included in the study for detailed data extraction (VC, IB, JB). The themes covered in the articles range from PPI in the education and skills training of health care staff, PPI in design, development and evaluation of health care services and products, quality improvement, patient safety, infectious disease control, crisis management, mental health and health promotion. While data extraction has been completed, data synthesis is still ongoing at the time of abstract submission. An updated search is planned for December 2022. With this mapping review of systematic reviews, we hope to provide an overview of the field and some guidance to those wanting to involve patients, caregivers and the public in their upcoming projects. References [1] Greenhalgh T, et al. Frameworks for supporting patient and public involvement in research: Systematic review and co-design pilot. Health Expectations 2019;22(4):785-801. DOI: 10.1111/hex.12888. [2] Ocloo J, et al. Exploring the theory, barriers and enablers for patient and public involvement across health, social care and patient safety: a systematic review of reviews. Health Research Policy and Systems 2021;19(1):8. DOI: 10.1186/s12961-020-00644-3.